AvantGuard
PrivateLast Round
Seed
Jun 24, 2026
Total Funding Raised
$14.9M
Company Overview
AvantGuard is a healthcare company that develops antimicrobial technologies, including its flagship molecule Avantamine, designed to combat pathogens on surfaces and skin.
Sector
Frontier & Industrial Tech
Verticals
Advanced Materials, Sustainable Materials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AvantGuard Comparables
Compare AvantGuard with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kismet Technologies | 79% | |
| Allied BioScience | 79% | |
| Kastus Technologies | 62% | |
AvantGuard Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 24, 2026 | ||||
| Grant | Nov 10, 2025 | ||||
| Grant | Jun 7, 2023 | ||||
| Seed | May 11, 2023 | ||||
| Grant | Apr 19, 2023 | ||||
Grant | Sep 29, 2022 |
AvantGuard Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Launch NY | Seed |
| NIH RADx | Grant |
| Blue Ledge Capital | Seed |
| Empire State Development | Grant |
| FuzeHub | Grant |
| Red Bear Ventures | Seed, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 18, 2025
Introduced AVA-003, a new antiseptic compound.
- Apr 19, 2023
$1.7M grant from NIH RADx and HHS.
AvantGuard Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AvantGuard's valuation, stock price, and market status.